The initial foray into genomic sequencing two decades ago has led to the discovery of key driver mutations and spurred drug development, thereby transforming the management of imminently lethal diseases.
By the end of World War I, the use of chemical weapons had resulted in over one million casualties on both sides, including many disabled and wounded. Through a series of unintended events, these chemical weapons set in motion discoveries that led to the development of chemotherapy.